8.4.2026 11:02:53 CEST | Demant A/S |
Antal stemmerettigheder og kapital
Selskabsmeddelelse nr. 2026-07
8. april 2026
Gennemførelse af kapitalnedsættelse i Demant A/S
Som oplyst i selskabsmeddelelse nr. 2026-05 blev det på Demant A/S’ ordinære generalforsamling den 5. marts 2026 besluttet at nedsætte selskabets aktiekapital med nominelt DKK 408.274,40 fordelt på 2.041.372 stk. aktier a DKK 0,20 svarende til selskabets beholdning af egne aktier pr. 3. februar 2026 fraregnet aktier til dækning af ledende medarbejderes og direktionens aktiebaserede fastholdelsesprogrammer.
Offentliggørelse af kapitalnedsættelsen har fundet sted i Erhvervsstyrelsens it-system den 6. marts 2026. Proklamafristen er udløbet uden indsigelser. Kapitalnedsættelsen er derfor anmeldt endeligt til Erhvervsstyrelsen. Efter kapitalnedsættelsen udgør aktiekapitalen i Demant A/S nominelt DKK 42.350.658,20.
I henhold til § 32 i lov om kapitalmarkeder oplyses det hermed, at selskabets samlede aktiekapital og samlede antal stemmerettigheder er opgjort til:
Aktiekapital (nominelt): DKK 42.350.658,20
Antal stemmerettigheder: 211.753.291
Yderligere information:
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Maribel Alonso Francisco, Communication Manager
Telefon +45 3917 7300
www.demant.com
Kontakter
Maribel Alonso Francisco, Communication Manager, +45 3171 9261, msbl@demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2026-07 Gennemførelse af kapitalnedsættelse.pdf
8.4.2026 11:02:53 CEST | Demant A/S |
Total number of voting rights and capital
Company announcement no 2026-07
8 April 2026
Completion of capital reduction in Demant A/S
As stated in company announcement no. 2026-05, it was decided at Demant A/S’ ordinary general meeting on 5 March 2026 to reduce the company’s share capital by nominally DKK 408,274.40 divided into 2,041,372 shares of DKK 0.20, corresponding to the company’s holding of treasury shares as at 3 February 2026 less shares to cover share-based retention programmes for senior leadership and the Executive Board.
The capital reduction was published via the electronic information system of the Danish Business Authority on 6 March 2026. The advertisement period expired without any objections being raised. Consequently, we have notified the Danish Business Authority of the capital reduction. After the capital reduction, the share capital of Demant A/S amounts to nominally DKK 42,350,658.20.
In accordance with section 32 of the Danish Capital Markets Act, we hereby state that the company’s total share capital and total number of voting rights amount to:
Share capital (nominal): DKK 42,350,658.20
Number of voting rights: 211,753,291
Further information:
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Maribel Alonso Francisco, Communication Manager
Phone +45 3917 7300
www.demant.com
Contacts
Maribel Alonso Francisco, Communication Manager, +45 3171 9261, msbl@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2026-07 Completion of capital reduction.pdf
